Lene Dissing Sjö
Clinical Associate Professor
1 - 1 out of 1Page size: 25
- 2018
- Published
Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon-independent manner
Dimopoulos, K., Søgaard Helbo, A., Fibiger Munch-Petersen, H., Sjö, Lene Dissing, Christensen, J., Sommer Kristensen, L., Asmar, F., Hermansen, N. E. U., O'Connel, C., Gimsing, P., Liang, G. & Grønbæk, Kirsten, Feb 2018, In: Molecular Oncology. 12, 2, p. 180-195Research output: Contribution to journal › Journal article › Research › peer-review
ID: 6945
Most downloads
-
381
downloads
TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy
Research output: Contribution to journal › Journal article › Research
Published -
200
downloads
Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
127
downloads
Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon-independent manner
Research output: Contribution to journal › Journal article › Research › peer-review
Published